For CA’s members with manufacturing facilities this story may of be interest to you: The Minister of Environment and Climate Change, the Honourable Jonathan Wilkinson, welcomed Royal Assent of […]
Objectives This introductory course on CEPA will help you learn and understand: our industry’s responsibilities under CEPA for cosmetics, drugs and natural health products which materials are covered under […]
Coal Tars The Final Screening Assessment for Coal Tars and their Distillates was published. The Risk Management Approach for Coal Tars and their Distillates and the proposed order adding […]
On June 30th, The International Fragrance Association (IFRA) standards have recently been updated to prohibit the use of Mintlactone (CAS 13341-72-5) as a fragrance ingredient. Please find below more […]
On June 29, 2021, the Health Products Compliance Directorate posted two drug Good Manufacturing Practices (GMP) guidance documents to their website. These documents are: Cleaning validation guide (GUI-0028) […]
As part of the Self-Care Framework, Health Canada has published Phase I on June 26th which are the proposed regulations to Improve Natural Health Product Labelling for a 70-day […]
As expected, Health Canada today launched Phase 1 of the implementation of the Self-Care Framework with the “pre-publication” in Canada Gazette Part 1 of a proposal to amend the Natural […]
Background There has been media coverage in both the U.S. and Canada regarding a recently published study finding various trace levels of PFAS (per- and polyfluoroalkyl substances) in […]
The Authority is consulting on its proposed 2021 Registry fees for Blue Box materials and Hazardous and Special Products (HSP). These are fees that registrants pay to the Authority […]
The Government of Ontario has finalized the Hazardous and Special Products (HSP) Regulation under the Resource Recovery and Circular Economy Act, 2016. The regulation sets requirements for producers that […]
